SBC Medical Group (NASDAQ:SBC) Sets New 52-Week High – What’s Next?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC)’s stock price reached a new 52-week high on Thursday. The company traded as high as $5.61 and last traded at $5.6040, with a volume of 61,660 shares. The stock had previously closed at $5.54.

Wall Street Analyst Weigh In

SBC has been the topic of a number of research analyst reports. BTIG Research reissued a “buy” rating and issued a $8.00 target price on shares of SBC Medical Group in a research report on Thursday, August 13th. Wall Street Zen upgraded SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 5th. Finally, Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $8.50.

SBC Medical Group Stock Up 2.7%

The company has a market capitalization of $585.22 million, a PE ratio of 12.11, a PEG ratio of 2.45 and a beta of 0.56. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09. The business has a fifty day moving average of $4.62 and a 200 day moving average of $3.75.

SBC Medical Group (NASDAQ:SBC) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The business had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million. SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. Equities research analysts anticipate that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC purchased a new position in SBC Medical Group in the 3rd quarter valued at approximately $36,000. Williams & Novak Wealth Management LLC grew its stake in shares of SBC Medical Group by 40.9% in the third quarter. Williams & Novak Wealth Management LLC now owns 26,330 shares of the company’s stock worth $130,000 after acquiring an additional 7,644 shares in the last quarter. State Street Corp increased its position in shares of SBC Medical Group by 59.7% during the second quarter. State Street Corp now owns 49,239 shares of the company’s stock worth $152,000 after acquiring an additional 18,400 shares during the period. Citadel Advisors LLC purchased a new stake in shares of SBC Medical Group during the second quarter worth $446,000. Finally, Two Sigma Securities LLC purchased a new stake in shares of SBC Medical Group during the second quarter worth $66,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.